Last reviewed · How we verify

[14C] CR845

Cara Therapeutics, Inc. · Phase 1 active Small molecule

At a glance

Generic name[14C] CR845
SponsorCara Therapeutics, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.